In July, India’s domestic pharma retail market experienced an 11% growth, driven by sales of anti-infectives and pain-relief medicines due to increased flu and viral infections. Augmentin emerged as the top-selling brand with Rs 72 crore in sales. Acute therapies, including pain and anti-infectives, grew by 11%, while chronic medications increased by 12%.
Related Posts
Record-breaking wildfires scorch more than 1.4 million acres in Oregon, authorities say
- staff
- August 11, 2024
- 0
Blazes have scorched more than 1.4 million acres, or nearly 2,200 square miles (5,700 square kilometers), Northwest Interagency Coordination Center spokesperson Carol Connolly said. That’s […]
India’s factory growth cooled to eight-month low in September, PMI shows
India’s manufacturing growth slowed to an eight-month low in September due to weakening demand and output, although it has stayed above the contraction threshold since […]
Stock market today: BSE Sensex, Nifty50 open flat for trade
Stock market today: Indian equity benchmark indices, BSE Sensex and Nifty50, opened flat on Tuesday. While BSE Sensex was above 81,000, Nifty50 was near 24,750 […]